Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5669706 | Reumatología Clínica | 2017 | 12 Pages |
Abstract
A total of eighteen recommendations were developed for the management of this patient profile. Fourteen of these recommendations were related to drug safety aspects. Recommendations on contraindication and toxicity of MTX have been updated. The experts recommend the use of biological monotherapy, a preferred treatment option, in patients whose profiles reveal a contraindication, intolerance or circumstances that prevent us against the use of MTX. There is some high-quality scientific evidence that supports contraindication and establishes certain conditions of MTX use in RA patients with specific clinical profiles.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Rosario GarcÃa-Vicuña, MarÃa Auxiliadora MartÃn-MartÃnez, MarÃa Rosa Gonzalez-Crespo, Jesús Tornero-Molina, Antonio Fernández-Nebro, Francisco Javier Blanco-GarcÃa, Ricardo Blanco-Alonso, Sara Marsal-Barril,